Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: A randomized clinical trial

Contraception

Volumn 92, Issue 4, 2015, Pages 301-307

  Shaaban, Omar M ^a   Ali, Mohammed K ^a   Sabra, Ali Mohamed A ^a   Abd El Aal, Diaa Eldeen M ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

Adenomyosis; COCs; Dysmenorrhea; LNG IUS; Mirena

Indexed keywords

ETHINYLESTRADIOL; GESTODENE; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADENOMYOSIS; ADULT; ARTICLE; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MENSTRUATION; OUTCOME ASSESSMENT; PELVIC PAIN; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; UTERUS BLEEDING; UTERUS BLOOD FLOW; VASCULAR RESISTANCE; VISUAL ANALOG SCALE; COMPARATIVE STUDY; DRUG EFFECTS; INTRAUTERINE CONTRACEPTIVE DEVICE; PATHOPHYSIOLOGY; UTERUS; VASCULARIZATION;

ADENOMYOSIS; ADULT; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; UTERUS;

EID: 84941738039     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2015.05.015     Document Type: Article

References (21)

1. M. Jason, V. Dechenne, F. Chantraine, and M. Nisolle Adenomyosis Rev Med Liege 68 2013 160 162
2. A. Uysal, C.E. Taner, S. Mun, F. Uysal, and F.H. Celimli Use of a levonorgestrel-releasing intrauterine device in the treatment of adenomyosis associated heavy menstrual bleeding J Pak Med Assoc 63 2013 1349 1352
3. C. Huchon, and A. Fauconnier Adenomyosis Rev Prat 64 2014 551 552
4. A. Shrestha, and L.B. Sedai Understanding clinical features of adenomyosis: a case control study Nepal Med Coll J 14 2012 176 179
5. S. Sanghera, T.E. Roberts, P. Barton, E. Frew, J. Daniels, L. Middleton, and et al. Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trial PLoS One 9 2014 e91891
6. M.N. Beatty, and P.D. Blumenthal The levonorgestrel-releasing intrauterine system: safety, efficacy, and patient acceptability Ther Clin Risk Manag 5 2009 561 574
7. S.W. Guo, X. Mao, Q. Ma, and X. Liu Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis Fertil Steril 99 2013 231 240
8. M.M. Shaaban, M.S. Zakherah, S.A. El-Nashar, and G.H. Sayed Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial Contraception 83 2011 48 54
9. K. Sakhel, and A. Abuhamad Sonography of adenomyosis J Ultrasound Med 31 2012 805 808
10. R. Champaneria, P. Abedin, J. Daniels, M. Balogun, and K.S. Khan Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy Acta Obstet Gynecol Scand 89 2010 1374 1384
11. M. Hanafi Ultrasound diagnosis of adenomyosis, leiomyoma, or combined with histopathological correlation J Hum Reprod Sci 6 2013 189 193
12. A.M. Bragheto, N. Caserta, L. Bahamondes, and C.A. Petta Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging Contraception 76 2007 195 199
13. S. Cho, A. Nam, H. Kim, D. Chay, K. Park, D.J. Cho, and et al. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis Am J Obstet Gynecol 198 2008 10.1016/j.ajog.2007.10.798
14. Z. Zheng, N.N. Wang, J.H. Wang, X.Q. Gan, Q.Q. Zheng, and P.Q. Ke Effect of levonorgestrel-releasing intrauterine system combined with GnRH analogue for treatment of large adenomyosis Nan Fang Yi Ke Da Xue Xue Bao 30 2010 541 543
15. M. Dueholm, E. Lundorf, J.S. Sorensen, S. Ledertoug, F. Olesen, and H. Laursen Reproducibility of evaluation of the uterus by transvaginal sonography, hysterosonographic examination, hysteroscopy and magnetic resonance imaging Hum Reprod 17 2002 195 200
16. I. Streuli, J. Dubuisson, P. Santulli, D. de Ziegler, F. Batteux, and C. Chapron An update on the pharmacological management of adenomyosis Expert Opin Pharmacother 15 2014 2347 2360
17. S. Deng, J.H. Lang, J.H. Leng, Z.F. Liu, D.W. Sun, and L. Zhu Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis Zhonghua Fu Chan Ke Za Zhi 41 2006 664 668
18. Y. Bayoglu Tekin, B. Dilbaz, S.K. Altinbas, and S. Dilbaz Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue Fertil Steril 95 2011 492 496
19. L. Fedele, S. Bianchi, R. Raffaelli, A. Portuese, and M. Dorta Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device Fertil Steril 68 1997 426 429
20. H. Maia, A. Maltez, G. Coelho, C. Athayde, and E.M. Coutinho Insertion of Mirena after endometrial resection in patients with adenomyosis J Am Assoc Gynecol Laparosc 10 2003 512 516
21. R. Dmitrovic, A.R. Kunselman, and R.S. Legro Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial Obstet Gynecol 119 2012 1143 1150